Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Tribal Group (TRB) by Hot Stock Rockets in ShareProphets
- Sell Time Out Group (TMO) by Steve Moore in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Overweight Future (FUTR) by JP Morgan
- Avoid Future (FUTR) by Steve Moore in ShareProphets
- Neutral Kingfisher (KGF) by UBS
- Buy Hilton Food Group (HFG) by Berenberg
- Buy Future (FUTR) by Deutsche Bank
- Buy National Grid (NG.) by Deutsche Bank
- Buy Burberry Group (BRBY) by Deutsche Bank
- Neutral Sage Group (SGE) by Goldman Sachs
- Overweight Berkeley Group Holdings (The) (BKG) by JP Morgan
- Watch BP (BP.) by Andrew Mackie in The Motley Fool
- Buy 3i Group (III) by UBS
- Buy Grainger (GRI) by Citi
- Outperform Persimmon (PSN) by RBC Capital
- Outperform Taylor Wimpey (TW.) by RBC Capital
- Underperform Vistry Group (VTY) by RBC Capital
- Outperform Crest Nicholson Holdings (CRST) by RBC Capital
- Underperform MJ Gleeson (GLE) by RBC Capital
Verici DX (VRCI) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Verici DX (VRCI)
| Latest Bid : 0.45p | Latest Ask : 0.50p |
| High Today : 0.55p | Low Today : 0.45p |
| This Years High : 3.25p | This Years Low : 0.45p |
| Volume : 2,043,611 | MKT Cap : £1.16M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Verici DX (VRCI) Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.Verici DX (VRCI) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | 4.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 61.60% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 68.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 90.40% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 94.35% |
Verici DX (VRCI) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.45p | Latest Ask : 0.50p |
| High Today : 0.55p | Low Today : 0.45p |
| This Years High : 3.25p | This Years Low : 0.45p |
| Volume : 2,043,611 | MKT Cap : £1.16M |
Verici DX Overview
Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Verici DX Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2025-07-21 11:25:00 21/07/2025 | 4.00% |
| Sell | Steve Moore | Premium Only | 2025-06-11 16:25:00 11/06/2025 | 61.60% |
| Avoid | Steve Moore | Premium Only | 2025-04-07 11:10:00 07/04/2025 | 68.00% |
| Avoid | Steve Moore | Premium Only | 2024-10-11 14:50:00 11/10/2024 | 90.40% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 16:05:00 14/02/2024 | 94.35% |